Экспорт
Холдинг

ID ...... Создание производства фармпрепарата

  • Дата добавления

    31.03.2021
  • Последнее обновление

    16.04.2021
  • Тип работ

    Новое строительство
  • Местоположение

  • Полное описание

    ············ ···· ········ ·········· ········ ·········· ·········· ················ ······ ···· ·············· ········ ········ ······ ···· ·········· ········ ············ ················ ·············· ·········· ················ ·········· ·········· ·········· ······ ·············· ·········· ·············· ······ ···· ········ ········ ················ ················ ················ ·········· ·············· ···· ······ ················ ············ ·········· ·············· ···· ········ ······ ················ ········ ···· ······ ······ ·········· ············ ········ ·············· ················ ··········
  • Краткое описание

    Инвестор начнет выпускать в Северо-Западном ФО кардиологический препарат. Объем выпуска продукции составит 6,5 млн упаковок ежегодно, что должно покрыть 100% потребностей российского рынка.
  • Стадия

  • Результаты интервью

    ···· ·················· ···· ····.····.········ ·········· ·················· ······ ································ ················ ·················· ·················· ············ ························ ·· ·················· ·········· ···· ························

  • Объем инвестиций

    ·············· ··············
  • Холдинг инвестора

Параметры проекта

  • Тип объекта

    ·········· ·························· ··············

Отраслевые параметры проекта

  • Производственная мощность

    ················ ················ ················ ·········· ······ ················ ········
  • Готовая продукция

    ········ ············ ········ ·············· ···· ················ ········ ···· ········ ················

Прогноз расхода материала

Материал

Инвестор

+ 9
Платформа инвестиционных проектов России <http://investprojects.info/projects/newmy?project_id=71217>
Вся информация, размещенная на данном веб-сайте, предназначена только для персонального пользования и не подлежит дальнейшему воспроизведению и / или распространению в какой-либо форме, иначе как с письменного разрешения Инвестиционной группы "Профессиональные Комплексные Решения" (ПКР)
Показать